Cambrex To Present At Rodman & Renshaw 16th Annual Global Investment Conference - KTVN Channel 2 - Reno Tahoe News Weather, Video -

Cambrex To Present At Rodman & Renshaw 16th Annual Global Investment Conference

  • Wendy Damonte's Health Watch ReportsMore>>

  • Request Remind Me 2 Kit

    Request a Remind Me 2 Kit

         More >>
  • Ask the Doctor: Pediatric Optometry

    Ask the Doctor: Pediatric Optometry

    Monday, September 15 2014 7:12 PM EDT2014-09-15 23:12:27 GMT
    Pediatric optometry is the focus of tonight's Ask the Doctor segment.More >>
    Pediatric optometry is the focus of tonight's Ask the Doctor segment.
    More >>
  • Premature Baby Heart Defect

    Premature Baby Heart Defect

    Monday, September 15 2014 2:35 PM EDT2014-09-15 18:35:05 GMT

    Specialists in Los Angeles have developed a minimally-invasive technique that corrects a common but potentially life-threatening heart problem in premature babies.

    More >>

    Specialists in Los Angeles have developed a minimally-invasive technique that corrects a common but potentially life-threatening heart problem in premature babies.

    More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Cambrex Corporation

EAST RUTHERFORD, N.J., Sept. 3, 2014 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steven M. Klosk, President and Chief Executive Officer, will present at the Rodman and Renshaw 16th Annual Global Investment Conference on September 10, 2014 at 1:15 p.m. EDT in New York City.

The live audio webcast and slide presentation can be accessed from the Cambrex website at www.cambrex.com in the Investors section under "Webcasts & Presentations", and a replay will be available for 90 days after the live event concludes. 

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit http://www.cambrex.com/

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.